Ascend Stack (Semaglutide · Cagrilintide · Lipo-C vials)

The Ascend Stack combines two long-acting metabolic peptides with a lipotropic compounded solution, supplied as three separate vials. Semaglutide and cagrilintide arrive as lyophilized powders requiring reconstitution, while Lipo-C is supplied as a ready-made liquid. Semaglutide is an acylated GLP-1 receptor agonist carrying an aminoisobutyric acid substitution at position 8 to resist DPP-4 cleavage and a C18 fatty diacid side chain that binds serum albumin. Cagrilintide is a long-acting analogue of amylin, engineered for solubility and stability. Lipo-C is a lipotropic solution combining methionine, inositol, and choline with cyanocobalamin and L-carnitine.

Peptide

Semaglutide, Cagrilintide

Strength

mg

Package

3-vial stack

Purity

≥99% by HPLC

Form

vial